132 related articles for article (PubMed ID: 32228915)
21. Absorption, accumulation and biological effects of depleted uranium in Peyer's patches of rats.
Dublineau I; Grison S; Grandcolas L; Baudelin C; Tessier C; Suhard D; Frelon S; Cossonnet C; Claraz M; Ritt J; Paquet P; Voisin P; Gourmelon P
Toxicology; 2006 Oct; 227(3):227-39. PubMed ID: 16978755
[TBL] [Abstract][Full Text] [Related]
22. Self-emulsifying drug delivery system for enhanced solubility of asenapine maleate: design, characterization, in vitro, ex vivo and in vivo appraisal.
Avasarala H; Dinakaran SK; Kakaraparthy R; Jayanti VR
Drug Dev Ind Pharm; 2019 Apr; 45(4):548-559. PubMed ID: 30623677
[TBL] [Abstract][Full Text] [Related]
23. Transepithelial transport of large particles in rat: a new model for the quantitative study of particle uptake.
Limpanussorn J; Simon L; Dayan AD
J Pharm Pharmacol; 1998 Jul; 50(7):753-60. PubMed ID: 9720624
[TBL] [Abstract][Full Text] [Related]
24. Oral Prion Neuroinvasion Occurs Independently of PrP
Marshall A; Bradford BM; Clarke AR; Manson JC; Mabbott NA
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021891
[TBL] [Abstract][Full Text] [Related]
25. Total parenteral nutrition increases uptake of latex beads by Peyer's patches.
Khan J; Iiboshi Y; Nezu R; Chen K; Cui L; Yoshida H; Wasa M; Fukuzawa M; Kamata S; Takagi Y; Okada A
JPEN J Parenter Enteral Nutr; 1997; 21(1):31-5. PubMed ID: 9002082
[TBL] [Abstract][Full Text] [Related]
26. Poly (lactide-co-glycolide) particles of different physicochemical properties and their uptake by peyer's patches in mice.
Shakweh M; Besnard M; Nicolas V; Fattal E
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):1-13. PubMed ID: 16005619
[TBL] [Abstract][Full Text] [Related]
27. Cell uptake and oral absorption of titanium dioxide nanoparticles.
Janer G; Mas del Molino E; Fernández-Rosas E; Fernández A; Vázquez-Campos S
Toxicol Lett; 2014 Jul; 228(2):103-10. PubMed ID: 24793716
[TBL] [Abstract][Full Text] [Related]
28. Oral Vaccination Through Peyer's Patches: Update on Particle Uptake.
Pais Soares EF; Fernandes Borges OM
Curr Drug Deliv; 2018; 15(3):321-330. PubMed ID: 28847272
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
30. Peyer's Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo.
Yano A; Takahashi K; Mori Y; Watanabe S; Hanamura Y; Sugiyama T; Inoue N
Biol Pharm Bull; 2018; 41(2):190-197. PubMed ID: 29386479
[TBL] [Abstract][Full Text] [Related]
31. The role of the Peyer's patch in carcinogenesis. I. The adsorption from the gut and retention of 3-methylcholanthrene by Peyer's patches.
Bost KL; Cuchens MA
Carcinogenesis; 1986 Aug; 7(8):1251-6. PubMed ID: 3731379
[TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo comparative study of itraconazole bioavailability when formulated in highly soluble self-emulsifying system and in solid dispersion.
Park MJ; Ren S; Lee BJ
Biopharm Drug Dispos; 2007 May; 28(4):199-207. PubMed ID: 17377960
[TBL] [Abstract][Full Text] [Related]
33. 2-Monoacylglycerol Mimetic Liposomes to Promote Intestinal Lymphatic Transport for Improving Oral Bioavailability of Dihydroartemisinin.
Zheng B; Pan F; Shi M; He C; He B; Wang R; Ren G; Yang S; Zhang S
Int J Nanomedicine; 2024; 19():5273-5295. PubMed ID: 38859952
[TBL] [Abstract][Full Text] [Related]
34. Lectin-bearing polymerized liposomes as potential oral vaccine carriers.
Chen H; Torchilin V; Langer R
Pharm Res; 1996 Sep; 13(9):1378-83. PubMed ID: 8893278
[TBL] [Abstract][Full Text] [Related]
35. Identification of cell adhesion molecules in the human follicle-associated epithelium that improve nanoparticle uptake into the Peyer's patches.
Gullberg E; Keita AV; Salim SY; Andersson M; Caldwell KD; Söderholm JD; Artursson P
J Pharmacol Exp Ther; 2006 Nov; 319(2):632-9. PubMed ID: 16914557
[TBL] [Abstract][Full Text] [Related]
36. In vivo phage display to identify M cell-targeting ligands.
Higgins LM; Lambkin I; Donnelly G; Byrne D; Wilson C; Dee J; Smith M; O'Mahony DJ
Pharm Res; 2004 Apr; 21(4):695-705. PubMed ID: 15139528
[TBL] [Abstract][Full Text] [Related]
37. The effects of epiphyseal peptides on the release of immunoglobulins in Peyer's patches in rats in vitro.
Zimina OA; Kovalenko RI; Nozdrachev AD
Neurosci Behav Physiol; 2003 Nov; 33(9):893-7. PubMed ID: 14969428
[TBL] [Abstract][Full Text] [Related]
38. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
[TBL] [Abstract][Full Text] [Related]
39. Incorporation of the reovirus M cell attachment protein into small unilamellar vesicles: incorporation efficiency and binding capability to L929 cells in vitro.
Rubas W; Banerjea AC; Gallati H; Speiser PP; Joklik WK
J Microencapsul; 1990; 7(3):385-95. PubMed ID: 2384840
[TBL] [Abstract][Full Text] [Related]
40. Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment.
Torché AM; Jouan H; Le Corre P; Albina E; Primault R; Jestin A; Le Verge R
Int J Pharm; 2000 May; 201(1):15-27. PubMed ID: 10867261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
